glp 1 drugs and inflammation GLP-1 Agonists - What is it? The GLP-1 revolution: What UAB

Originally designed to manage type 2 diabetes (T2D), these drugs have rapidly expanded their therapeutic reach, offering significant benefits for ob

Medicare has never paid for weight-loss drugs at scale

This and other trials have shown improvements in patients lipid profiles with the most pronounced impact on reduction of triglycerides

Loss of muscle mass and strength not only impairs mobility and quality of life, but also worsens insulin resistance, ...

As 2025 gets underway, we take a look at what lies ahead for the highly dynamic market for effective anti-obesity medications (AOMs)

That rule is a heuristic, not a biological law